Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HIV-associated lymphomas].

C Scheidegger1, B Heinrich, M Popescu

  • 1I. Medizinische Abteilung, Klinikum Grosshadern der Universität, München.

Deutsche Medizinische Wochenschrift (1946)
|July 26, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From cradle to grave? A global hotspot and new species of the genus Lobaria discovered in the Himalayas and the Hengduan Mountains.

Persoonia·2024
Same author

Modified pyridine-triazole and 2,2'-bipyrimidine ligands generating robust titanium complexes constructed around a TiO<sub>4</sub>N<sub>2</sub> core.

Dalton transactions (Cambridge, England : 2003)·2021
Same author

Evaluating methodologies for species delimitation: the mismatch between phenotypes and genotypes in lichenized fungi (<i>Bryoria</i> sect. <i>Implexae</i>, <i>Parmeliaceae</i>).

Persoonia·2019
Same author

A robust Ti(iv)-based mesogen constructed around a TiO<sub>4</sub>N<sub>2</sub> core.

Dalton transactions (Cambridge, England : 2003)·2019
Same author

Successful therapy for pyoderma gangrenosum with a Janus kinase 2 inhibitor.

The British journal of dermatology·2018
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same journal

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026
Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026
See all related articles

This study on HIV-associated lymphomas in Central Europe found that early-stage, high-grade non-Hodgkin lymphoma responded well to treatment. However, advanced stages and central nervous system involvement significantly impacted survival for these patients.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Hematology

Background:

  • Human Immunodeficiency Virus (HIV) infection is associated with an increased risk of various cancers, particularly lymphomas.
  • Understanding the clinical and pathological spectrum of HIV-associated lymphomas is crucial for effective management in Central Europe.
  • Previous studies have highlighted the aggressive nature and poor prognosis of these malignancies.

Purpose of the Study:

  • To explore the clinical and pathological spectrum of HIV-associated lymphomas in Central European homosexual men.
  • To evaluate the therapeutic aspects and survival outcomes for patients with HIV-associated lymphomas.
  • To identify prognostic factors influencing patient survival.

Main Methods:

  • Retrospective analysis of 41 HIV-positive homosexual men diagnosed with malignant lymphomas.

Related Experiment Videos

  • Classification of lymphomas into Hodgkin's disease and non-Hodgkin lymphoma (high and low malignancy).
  • Assessment of disease stage at diagnosis and treatment response (chemotherapy, irradiation).

    • Main Results:

    • The mean survival period after diagnosis was 5.5 months, significantly influenced by lymphoma stage.
    • Early-stage (I and II) high-grade non-Hodgkin lymphoma showed good response rates (8/9 complete and lasting remissions) to chemotherapy or irradiation.
    • Advanced stages (III and IV) and primary central nervous system involvement resulted in poor prognosis and minimal survival prolongation.
    • Overall treatment response rate was 75% (45% complete remission). Hodgkin's disease responded initially but recurred in all cases.

    Conclusions:

    • HIV-associated lymphomas, particularly high-grade non-Hodgkin lymphoma, present a significant challenge in Central Europe.
    • Early diagnosis and treatment of lymphoma in HIV-positive individuals are critical for improving outcomes.
    • Prognosis is heavily dependent on the stage of the lymphoma at diagnosis, with advanced disease and CNS involvement conferring a poor outlook.